Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-09 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-09 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.32 | 1e-08 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.27 | 1e-08 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |